In the STZ-induced mouse model of type 1 diabetes, NGFR mediates the release of ligand-dependent inflammatory cytokines, disrupts glial-vascular units, and promotes blood-retinal barrier breakdown (Barcelona et al., 2016). Here, NGFR is linked to type 1 diabetes mellitus.